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Abstract
Background: Recommended statistical methods for meta-analysis of diagnostic test accuracy studies require
relatively complex bivariate statistical models which can be a barrier for non-statisticians. A further barrier exists in
the software options available for fitting such models. Software accessible to non-statisticians, such as RevMan, does
not support the fitting of bivariate models thus users must seek statistical support to use R, Stata or SAS. Recent
advances in web technologies make analysis tool creation much simpler than previously. As well as accessibility,
online tools can allow tailored interactivity not found in other packages allowing multiple perspectives of data to
be displayed and information to be tailored to the user’s preference from a simple interface. We set out to: (i)
Develop a freely available web-based “point and click” interactive tool which allows users to input their DTA study
data and conduct meta-analyses for DTA reviews, including sensitivity analyses. (ii) Illustrate the features and
benefits of the interactive application using an existing DTA meta-analysis for detecting dementia.
Methods: To create our online freely available interactive application we used the existing R packages lme4 and
Shiny to analyse the data and create an interactive user interface respectively.
Results: MetaDTA, an interactive online application was created for conducting meta-analysis of DTA studies. The
user interface was designed to be easy to navigate having different tabs for different functions. Features include the
ability for users to enter their own data, customise plots, incorporate quality assessment results and quickly conduct
sensitivity analyses. All plots produced can be exported as either .png or .pdf files to be included in report
documents. All tables can be exported as .csv files.
Conclusions: MetaDTA, is a freely available interactive online application which meta-analyses DTA studies, plots
the summary ROC curve, incorporates quality assessment results and allows for sensitivity analyses to be conducted
in a timely manner. Due to the rich feature-set and user-friendliness of the software it should appeal to a wide
audience including those without specialist statistical knowledge. We encourage others to create similar
applications for specialist analysis methods to encourage broader uptake which in-turn could improve research
quality.
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Background
Background to meta-analysis of diagnostic test accuracy
studies
Diagnostic tests are routinely used in healthcare settings
for confirming or excluding diagnoses. They generally
comprise of a measure which splits individuals into
healthy or diseased. Diagnostic tests in primary care can
generally be done on any patient and are normally quick
and painless. In hospital settings, diagnostic tests can be
more invasive and expensive, and are often only carried
out on specific populations of individuals where the tests
may be necessary to determine treatment pathways [1].
Diagnostic tests have been around for a long time.
However, as our understanding of biology and disease
has increased, along with advances in technology, many
new diagnostic tests have emerged and there is now a
plethora of diagnostic tests available [1]. For example,
with some conditions, such as cancer, studies aim to
identify a new diagnostic test that is still as accurate as
the standard test, yet less costly or invasive. Diagnostic
tests are rarely 100% accurate so rigorous testing is re-
quired [1]. There can be many aspects to evaluating a
diagnostic test including ability to measure the desired
parameter, cost-effectiveness and accuracy. In this paper
we focus on assessing the accuracy of diagnostic tests.
To assess accuracy, a diagnostic test is compared to
the “gold standard” test which is assumed to provide the
true diagnosis of individuals. The value used to split the
population into healthy or diseased is known as the
threshold or cut-off value. The results of a diagnostic
test are often reported in a 2 × 2 table, as in Table 1. The
true positive (TP) rate is the number of patients cor-
rectly identified as having the disease by the diagnostic
test. The true negative (TN) rate is the number of pa-
tients correctly identified as not having the disease by
the diagnostic test. The false positive (FP) rate is the
number of patients who do not have the disease but
have a positive test result. The false negative (FN) rate is
the number of patients who have the disease but have a
negative test result. There are two parameters which are
often used to assess the accuracy of diagnostic tests; sen-
sitivity and specificity. Sensitivity is the ability of the
diagnostic test to correctly identify patients with the dis-
ease amongst patients who have the disease (i.e. TP/TP
+ FN). Specificity is the ability of the diagnostic test to
correctly identify the healthy individuals amongst
patients who do not have the disease (i.e. TN/FP + TN).
A meta-analysis (MA) of diagnostic test accuracy
(DTA) studies synthesises both sensitivity and specificity
from multiple studies to evaluate the performance of a
diagnostic test. DTA MA should take into account the
correlation between sensitivity and specificity and is
often performed using either the bivariate or hierarchical
summary receiver operating characteristic (HSROC)
models, and the results presented either around a mean
accuracy point or as a summary receiver operating char-
acteristic (SROC) curve [2–4]. The SROC curve plots
sensitivity on the y-axis against 1-specificity on the
x-axis illustrating how sensitivity and specificity vary for
different thresholds of a test.
Static versus interactive graphs
Conventionally, SROC curves are published as static
graphs. Static graphs can be limiting as they must
display all of their elements on the same surface at the
same time. Otherwise, to represent all the dimensions of
the data and illustrate the necessary perspectives, mul-
tiple static graphs must be produced [5]. An alternative
to static graphs is to consider interactive graphs. Inter-
activity allows multiple perspectives of the data to be
seen and can be made up of layers, allowing one space
to be used for describing multiple types of analyses
where each layer is only visible when the user selects it
[6]. Importantly, interactivity allows users to explore the
data themselves and can provide a useful tool to aid
sensitivity analyses. A trade-off exists between static
and interactive graphs between the time it takes to
generate the new image and the space needed to
present the many static graphs necessary to illustrate
the same point [6].
Why is an interactive online application needed?
Cochrane publish a number of diagnostic test accuracy
reviews each year. A search of the Cochrane Database of
Systematic Reviews on the 7th September 2018 identi-
fied 99 reviews of type ‘diagnostic’ published between
October 2009 and August 2018. However, the Cochrane
software RevMan [7] uses the Moses-Littenburg method
[8, 9] for DTA MA which does not properly take into
account random effects and the correlation between sen-
sitivity and specificity [10]. Therefore, using bivariate or
HSROC models is more appropriate for MA of DTA
studies [2]. To properly conduct DTA MA in RevMan
other programs such as Stata, SAS, R or WinBUGS are
needed to conduct the statistical analysis and then the
HSROC parameters are ‘fed back’ into RevMan to pro-
duce SROC plots. Furthermore, feedback from Cochrane
review teams highlighted frustrations with the complex-
ity of existing DTA MA software approaches. We set
out to develop an interactive application which could be
used by both researchers familiar with the DTA MA
Table 1 Illustration of a 2 × 2 table of diagnostic test results
Gold standard
Positive Negative
Index test Positive True Positives (TP) False Positives (FP)
Negative False Negatives (FN) True Negatives (TN)
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process, but who don’t necessarily have the statistical
expertise to use specialist software such as Stata or R,
and statisticians, to allow a comprehensive analysis of
their data and publication quality figures to be con-
ducted in a single package.
Sensitivity analysis is an essential part of any statistical
analysis. It allows examination of both data and assump-
tions. In MA sensitivity analysis is often conducted
excluding any particularly large or extreme studies, or
studies deemed to be of low quality to assess the robust-
ness of the parameter estimates from the primary
analysis. In software such as RevMan excluding one trial
involves running a new analysis. We set out to encour-
age sensitivity analyses within the application by allow-
ing trials to be excluded in an easy interactive manner.
A 2008 review investigating how diagnostic informa-
tion was graphically presented concluded that often
multiple graphs are needed to in order to provide both a
detailed overview of the results and to communicate the
information needed to inform clinical practice [11]. Fur-
thermore, effective interactive tools need to have appro-
priate statistical functioning, alongside high quality
graphics to provide a pleasant experience for the user
[12]. We considered graphical design alongside statistical
analysis to develop a user-friendly intuitive application
allowing users to explore their data, conduct sensitivity
analyses and assess the impact of assumptions on the
parameter estimates.
Objectives
We set out to develop a freely available web-based
“point and click” interactive online application which
allows users to input their own data and conduct
meta-analyses of diagnostic test accuracy study data
including sensitivity analyses. We illustrate the benefits
of the interactive application using an existing DTA MA
on assessing protein in cerebrospinal fluid to identify pa-
tients with mild cognitive impairment who would
develop dementia.
Implementation
We built MetaDTA, an interactive application to
facilitate analysis and aid understanding for researchers,
clinicians and students, focusing on the SROC plot.
Software
To create our online freely available interactive applica-
tion we used the statistical software R [13] and the
existing packages Shiny [14] and lme4 [15]. Shiny is a
package that allows R users to create web applications
with interactive user interfaces without prior knowledge
of web development languages such as HTML,
JavaScript and CSS [14]. lme4 is a package that fits
generalised linear mixed effect models [15]. MetaDTA is
hosted on the shinyapps server which makes it available
to any user with a web browser, without requiring any
specialist statistical software. The application is available
at https://crsu.shinyapps.io/dta_ma/.
Statistical analysis
The random effects bivariate binomial model of Chu &
Cole [4] is fitted as a generalised linear mixed effect
model using the glmer function from the package lme4
[15, 16]. Sensitivity and specificity are jointly modelled
and the estimates from each study are assumed to vary
but come from a common underlying distribution with
an unstructured between-study covariance matrix [16].
The bivariate model has been shown to be mathemat-
ically identical to the HSROC model [17]. Therefore the
HSROC parameters are estimated using the bivariate
model parameters and the equivalence equations of
Harbord et al. [17]. The SROC plot is drawn using the
resulting HSROC parameters. Positive and negative like-
lihood ratios and the diagnostic odds ratio are calculated
directly from the estimates of logit sensitivity and logit
specificity. The R package msm is used to implement
the delta method to calculate the standard errors of the
likelihood ratios and diagnostic odds ratio to allow
calculation of the confidence intervals [18].
Data on the quality of the primary diagnostic accuracy
studies, evaluated using the QUADAS-2 tool [19], can
be incorporated within SROC plots in MetaDTA. The
QUADAS-2 tool consists of four domains i) patient se-
lection, ii) index test, iii) reference standard, and iv) flow
of patients through the study and timing of the index
test(s) and reference standard. All domains are
assessed in terms of risk of bias, and domains i) to
iii) in terms of concerns regarding applicability to the
review question [19].
User Interface
The user interface was designed to be user-friendly and
intuitive and follows the process of conducting an ana-
lysis: Load Data, Meta-Analysis and Sensitivity Analysis.
All pages have been constructed with a sidebar on the
left displaying the options available for the user to select.
A fourth page, References, includes some of the key ref-
erences for the statistical methods and default datasets
used within MetaDTA.
The Load Data page offers users the option to upload
their own dataset in either a six column format or in a
thirteen column format in which the additional seven
columns contain quality assessment results from
QUADAS-2. The Load Data page is pre-loaded with two
inbuilt datasets: unhealthy alcohol use [20] and dementia
[21]. The unhealthy alcohol use dataset is the default
dataset and is in the six column format. The dementia
dataset contains quality assessment results and can be
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Fig. 1 Data for Analysis tab on the Load Data page. Data displayed is from the inbuilt dataset on assessing dementia
Fig. 2 Study-level Outcomes tab on the Meta-Analysis page. Estimates of sensitivity, specificity and false positive rate for each trial
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accessed by selecting ‘Yes’ to the question ‘Use a dataset
with quality assessment data?’ under the ‘Default dataset
options’ on the sidebar. Default datasets are overwritten
when users choose to upload their own dataset. The tab
‘Data for Analysis’ will always display the dataset being
analysed (Fig. 1).
The Meta-Analysis page consists of five tabs:
Study-level Outcomes, ROC curve, Statistics, Parameter
Estimates and Parameters for RevMan. The ‘Study-level
Outcomes’ tab presents estimates of the sensitivity, spe-
cificity and false-positive rate for each trial (Fig. 2).
Throughout MetaDTA all tables can be downloaded as
.csv files and all figures can be downloaded as either
.png or .pdf files.
On the ‘ROC curve’ tab users are able to choose
whether to display the data point from each trial, the
SROC curve, summary point, 95% confidence region,
95% predictive region and 95% confidence intervals for
sensitivity and specificity of each data point. When
SROC curve is selected users may also choose to ex-
trapolate the SROC curve. Users are able to specify their
own title for the plot. Additional functionality includes
displaying the sensitivity and false-positive rate below
the graph for the appropriate study when a data point is
clicked on. For datasets in the thirteen column format
an additional drop down menu contains the individual
domains from the QUADAS-2 tool. When a domain is
selected the data points on the ROC plot are coloured
dependent on their quality assessment score: green for
low risk of bias/applicability, red for high risk of bias/ap-
plicability and grey for unclear (Fig. 3). Choosing one of
two further options in the drop down menu, ‘Risk of bias
(all)’ or ‘Applicability concerns (all)’, will display pie
charts on the ROC plot summarising all domains of
QUADAS-2 concerning either risk of bias or applicabil-
ity respectively. In addition, when either of these options
is chosen and the user clicks on the middle of the pie
chart for a particular study a larger version of the pie
chart is displayed below the ROC plot.
The ‘Statistics’ tab tabulates point estimates and 95%
confidence intervals for the statistics selected by the user
from the list in the sidebar on the left (Fig. 4). The ‘Par-
ameter Estimates’ tab provides the bivariate normal dis-
tribution for mean sensitivity and specificity on the logit
Fig. 3 ROC curve tab on Meta-Analysis page. ROC curve showing data points, summary estimate, 95% confidence region, 95% predictive region
and HSROC curve for all trials. Data points have been coloured according to the patient selection domain for risk of bias from the QUADAS-2
tool. The sidebar on the left shows the options available to customise the plot
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scale which may be useful for further modelling such as
the inclusion of test accuracy in a decision modelling
framework (Fig. 5). The ‘Parameters for RevMan’ tab
provides the parameter values required by RevMan to
allow construction of plots in the ROC space for users
who wish to include the analysis results as part of a
Cochrane review (Fig. 6).
The Sensitivity Analysis page is similar in format to
the Meta-Analysis page, with an additional option in the
sidebar on the left which allows users to select
which studies they would like to include in their sensi-
tivity analysis. The ‘ROC curve’ tab displays in grey esti-
mates from studies included in the main analysis but
excluded from the sensitivity analysis. The overall pooled
estimate from the main analysis is also displayed in grey.
Estimates from the studies included in the sensitivity
analysis are displayed in black with the overall pooled
estimate from these studies in blue. For datasets in the
thirteen column format, if selected as an option, pie
charts summarising risk of bias or applicability concerns
are displayed in grey for studies excluded from the
sensitivity analysis (Fig. 7). The ‘Statistics’ tab displays
two tables: estimates from the sensitivity analysis and es-
timates from the analysis of all trials (Fig. 8).
Results
Illustrative example using dementia data
The dataset used to illustrate MetaDTA is taken from a
meta-analysis assessing protein in cerebrospinal fluid to
identify patients with mild cognitive impairment who
would develop Alzheimer’s disease dementia or other
forms of dementia [21]. The dataset consists of fourteen
studies. Figure 2 shows the estimates of sensitivity, speci-
ficity and false-positive rate from each trial.
Across the fourteen studies the pooled estimate of sen-
sitivity was 79.7% (95% confidence interval (CI): 72.2,
85.6%) and the pooled estimate of specificity was 65.4%
(95% CI: 55.8, 73.9%) (Figs. 3 & 4). From Fig. 2 it can be
seen that the Papaliagkas study has zero false negative
observations giving a sensitivity equal to 1. We chose to
conduct a sensitivity analysis to determine how influ-
ential this perfect sensitivity is on the mean estimates.
Fig. 4 Statistics tab on the Meta-Analysis page. Table shows estimates of sensitivity, specificity and false positive rate across all trials. The sidebar
on the left shows the options available to customise the table
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Removing the Papaliagkas study had little effect on
the pooled estimates of sensitivity and specificity. The
pooled estimate of sensitivity reduced slightly to
79.4% (95% CI: 71.6, 85.5%) whilst the false positive
rate reduced slightly to 64.4% (95% CI, 54.2, 73.5%)
(Figs. 7 & 8).
Decision making context
In England and Wales, the National Institute for
Health and Care Excellence (NICE) are responsible
for determining which treatments are available on
the NHS. Evidence synthesis feeds into economic
evaluations which inform clinical decision-making
by NICE. Bujkiewicz et al. demonstrated the feasi-
bility and usefulness of interactive applications
during a NICE Technology Appraisal meeting [22].
They developed an interactive Excel application,
Transparent Interactive Decision Interrogator
(TIDI), to allow for real-time sensitivity analyses
which was used during a NICE Technology Ap-
praisal meeting [22]. An Excel-based interface was
constructed including graphical controls which
allowed a range of assumptions to be explored.
Statistical analyses were conducted ‘behind the
scene’ using R and WinBUGS. Whilst the
Excel-based interface provided a familiar
user-interface, the application required the installa-
tion of both R and WinBUGS on the computer be-
ing used. Furthermore, the application required
statistical expertise as re-programming was needed
for each new dataset. However, a survey of com-
mittee members following the meeting found that
the application was viewed in a positive manner
providing support to decision makers by allowing a
range of scenarios and assumptions to be explored
in real time and speeding up the decision making
process [22].
An advantage of MetaDTA is that, unlike TIDI,
it does not require knowledge of any specialist
statistical software packages such as Stata, R or
WinBUGS to use. Furthermore, MetaDTA has the
potential to be developed further to aid in the de-
cision making process. MetaDTA already provides
the estimated parameters of the bivariate normal
distribution required for probabilistic sampling for
stochastic decision modelling based on the
Fig. 5 Parameter Estimates tab on the Meta-Analysis page. Table shows parameter estimates from the bivariate normal distribution for mean
sensitivity and specificity (on the logit scale) which may be useful for further modelling
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correlated mean estimates of accuracy from the
meta-analysis.
Further work could include the development of an
interface between MetaDTA and associated economic
decision models which could be used within meetings to
conduct real-time sensitivity analyses on a range of
scenarios and assumptions. Countries across the world
are using and/or developing their own formal decision
making processes (e.g. Canada, Australia, Brazil). There-
fore, the need for an online application to conduct
real-time analyses will continue to increase as the
number of countries adopting formal decision making
processes increases. Creating and sharing online re-
sources such as this app, which can be used worldwide
with just an internet browser, may minimise duplication
and effort across countries.
Discussion
We created MetaDTA, an online interactive ‘point-and--
click’ application for meta-analysis of DTA studies.
MetaDTA allows users to upload their own data, ana-
lyses the data and presents the results in downloadable
formats. We developed a user-friendly intuitive user
interface which allows users to explore their data and
the analysis. The application uses the statistically
rigorous bivariate model to analyse the data and much
of the data and results can be presented graphically via
an interactive SROC plot. There are many options avail-
able allowing users to customise the graphs to suit their
needs including the option to incorporate quality assess-
ment results from the QUADAS-2 tool. In addition, all
statistical parameter estimates are presented in tables
with uncertainty. All tables and figures can be down-
loaded from the application. Furthermore, we encourage
the use of sensitivity analyses by allowing users the
option to remove trials from the analysis.
We believe that sensitivity analysis is the key to ensur-
ing that an analysis is robust. However, some published
meta-analyses of DTA studies may hypothesise about
how their results could be affected by certain studies but
don’t always conduct sensitivity analyses. Sensitivity
analyses can be time-consuming and may involve ‘going
back to the start’ and creating a new dataset excluding
influential studies and running the analysis again.
MetaDTA avoids this allowing users to remove a study
through one click of a button and presenting the results
alongside the original analysis so that the impact of re-
moving a study can be seen visually in both figures and
Tables. A key element of sensitivity analyses is to assess
the impact of study quality on the DTA MA results.
Fig. 6 Parameters for RevMan tab on the Meta-Analysis page. Table shows parameter values require by RevMan to construct plots in the
ROC space
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MetaDTA allows the results of quality assessment from
the QUADAS-2 tool to be included in the uploaded data
file. An assessment of how the DTA MA results change
when low quality studies are excluded can then be easily
conducted by removing the low quality studies with re-
sults displayed visually in both figures and tables. We
believe that MetaDTA which allows customisable and
statistically informative graphics could improve the con-
duct of sensitivity analyses.
MetaDTA was developed by statisticians at the UK
National Institute of Health Research Complex Reviews
Support Unit (CRSU) with direct input from end-users.
MetaDTA was first presented at a CRSU workshop in
April 2018. Feedback from the meeting was positive and
requests for additional functionality, such as estimates
for the HSROC model, were incorporated into the appli-
cation. We are aware of several other standalone R pack-
ages which can be used to conduct the statistical
analyses required to meta-analyse DTA studies [16].
However, we are only aware of one R package which
both fits a bivariate model to synthesise DTA studies
and provides a user interface [23]. The package meta4diag
fits a Bayesian bivariate normal model and provides an
interactive graphical interface so that the full functionality
of the package can be accessed without requiring any R
programming. However, meta4diag requires users to have
R installed on their device and the results are presented as
R output requiring the user to have some R knowledge.
We believe MetaDTA has advantages over meta4diag as
the only software needed is an internet browser and that
the direct input from end-users has resulted in an applica-
tion that is truly user-friendly for both statisticians and
non-statisticians. As with all forms of statistical analysis,
we encourage users unfamiliar with the statistical method-
ology to seek statistical support to ensure correct inter-
pretation of the results.
Building on the concept of explorable explanations first
proposed by Bret Victor in 2011 [24] a further advantage of
this application is the potential to encapsulate a specific data-
set within the application. For example, as part of the online
Fig. 7 ROC curve tab on the Sensitivity-Analysis page. ROC curve showing data points, summary estimate, 95% confidence region, 95% predictive
region and HSROC curve for all trials excluding Papaliagkas. Analysis of all trials is shown in grey. Data points are displayed as pie charts
summarising the risk of bias domains from the QUADAS-2 tool
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supplementary material for a journal paper a link could be
placed which when followed takes the user to a version of
this application which contains the data reported in the jour-
nal paper. Explorable explanations enable and encourage the
reader to become an active participant in the learning
process allowing text to be used as an environment to
think in [25]. In this case, the user would be able to
explore the dataset themselves, repeat the analyses re-
ported in the paper, assess the impact of modelling
assumptions and conduct their own sensitivity ana-
lyses scrutinising any concerns they may have.
Conclusion
We built a freely available interactive online application
which meta-analyses DTA studies, produces the SROC
plot, incorporates quality assessment results and allows
for sensitivity analyses to be conducted in a timely man-
ner. MetaDTA will allow a wide range of users to carry
out specialised analyses without needing software
beyond an internet browser. We encourage others to
create similar applications for specialist analysis methods
to encourage broader uptake which in-turn could im-
prove research quality.
Fig. 8 Statistics tab on the Sensitivity Analysis page. Top table shows estimates of sensitivity, specificity and false positive rate across all trials.
Bottom table shows estimates of sensitivity, specificity and false positive rate across all trials excluding Gomez and Gordon
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Availability and requirements
Project name: MetaDTA (Diagnostic Test Accuracy
Meta-Analysis).
Project home page: https://crsu.shinyapps.io/dta_ma/
Operating system(s): Platform independent.
Programming language: R.
Other requirements: Internet browser.
License: Not applicable.
Any restrictions to use by non-academics: None.
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